Results 271 to 280 of about 9,616,743 (356)
Digital twins to accelerate target identification and drug development for immune‐mediated disorders
Digital twins integrate patient‐derived molecular and clinical data into personalised computational models that simulate disease mechanisms. They enable rapid identification and validation of therapeutic targets, prediction of drug responses, and prioritisation of candidate interventions.
Anna Niarakis, Philippe Moingeon
wiley +1 more source
Structural barriers to antifungal drug development. [PDF]
Galgóczy L.
europepmc +1 more source
5‐Aminolevulinic acid combined with ferric ammonium citrate (5‐ALA/FAC) stimulates dermal papilla cell activity and promotes hair follicle growth. The treatment enhances ERK and AKT signaling, increases hair‐inductive gene expression, and restores dermal papilla function suppressed by dihydrotestosterone and oxidative stress, resulting in enhanced hair
Han‐Wook Ryu, Eok‐Soo Oh, Sewoon Kim
wiley +1 more source
Access to Essential Medicines in Low- and Middle-Income Countries: A Systematic Review of Barriers and Facilitators. [PDF]
Herrera-Ramirez I +4 more
europepmc +1 more source
Targeting the gut-immune-brain axis: pharmacological insights from depression in inflammatory bowel disease. [PDF]
Simões JLB +3 more
europepmc +1 more source
693 drugs in essential drugs list.
openaire +1 more source
The application of ABC-VED with multi-criteria analysis for drug inventory management. [PDF]
Ayalew AB, Alemu AG, Worku AM.
europepmc +1 more source
FDA 2025 Cancer Drug Approvals: targeted therapy dominates. [PDF]
Jørgensen JT.
europepmc +1 more source

